Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10583274rdf:typepubmed:Citationlld:pubmed
pubmed-article:10583274lifeskim:mentionsumls-concept:C0018939lld:lifeskim
pubmed-article:10583274lifeskim:mentionsumls-concept:C0427526lld:lifeskim
pubmed-article:10583274lifeskim:mentionsumls-concept:C1704387lld:lifeskim
pubmed-article:10583274lifeskim:mentionsumls-concept:C1522642lld:lifeskim
pubmed-article:10583274lifeskim:mentionsumls-concept:C0443146lld:lifeskim
pubmed-article:10583274lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:10583274lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:10583274pubmed:issue3lld:pubmed
pubmed-article:10583274pubmed:dateCreated2000-1-31lld:pubmed
pubmed-article:10583274pubmed:abstractTextWe report a patient with clonal proliferation of CD3+8+TCRalphabeta+ large granular lymphocytes (LGL) presenting multiple episodes of autoimmune cytopenia, including autoimmune neutropenia, idiopathic thrombocytopenic purpura, autoimmune haemolytic anaemia, and pure red cell aplasia. Each disorder appeared separately or as a combination during an 11-year clinical course. The increase of blood CD3+8+TCRalphabeta+ LGL was detected 6 years after the initial diagnosis of cytopenia, but the absolute number of LGL cells was always < 1.0 x 109/l. LGL cells were of monoclonal origin and had a chromosomal abnormality. LGL cells transiently responded to cyclosporine A therapy, which was also effective on all of these autoimmune cytopenias. Accordingly, an undetectable level of proliferation of a clonal LGL population could cause various autoimmune haemopoietic disorders.lld:pubmed
pubmed-article:10583274pubmed:languageenglld:pubmed
pubmed-article:10583274pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10583274pubmed:citationSubsetIMlld:pubmed
pubmed-article:10583274pubmed:statusMEDLINElld:pubmed
pubmed-article:10583274pubmed:monthDeclld:pubmed
pubmed-article:10583274pubmed:issn0007-1048lld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:HaradaMMlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:HayashiSSlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:LaraF YFYlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:IwasakiHHlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:ShibuyaTTlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:AkashiKKlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:TeshimaTTlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:OkamuraTTlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:TaniguchiSSlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:TakamatsuYYlld:pubmed
pubmed-article:10583274pubmed:authorpubmed-author:GondoHHlld:pubmed
pubmed-article:10583274pubmed:issnTypePrintlld:pubmed
pubmed-article:10583274pubmed:volume107lld:pubmed
pubmed-article:10583274pubmed:ownerNLMlld:pubmed
pubmed-article:10583274pubmed:authorsCompleteYlld:pubmed
pubmed-article:10583274pubmed:pagination670-3lld:pubmed
pubmed-article:10583274pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:meshHeadingpubmed-meshheading:10583274...lld:pubmed
pubmed-article:10583274pubmed:year1999lld:pubmed
pubmed-article:10583274pubmed:articleTitleMultiple autoimmune haemopoietic disorders and insidious clonal proliferation of large granular lymphocytes.lld:pubmed
pubmed-article:10583274pubmed:affiliationFirst Department of Internal Medicine, Kyushu University, Fukuoka, Japan. akashi@leland.stanford.edulld:pubmed
pubmed-article:10583274pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10583274pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:10583274pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10583274lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10583274lld:pubmed